| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |